Haemonetics Corporation: Improved Performance, Another Bolt-On Deal [Seeking Alpha]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Seeking Alpha
Haemonetics has seen improvements in its business after a tough period during the pandemic, but its share price has lagged. The company's adjusted earnings multiples have fallen below 20 times, making its shares more reasonably priced. Looking for a helping hand in the market? Members of Value In Corporate Events get exclusive ideas and guidance to navigate any climate. Learn More » Shares of Haemonetics Corporation ( NYSE: HAE surfaced on my radar after the blood player announced another bolt-on acquisition early in March 2024, at a time when its shares have continued to lag. The company has finally seen some improvements as of recent after a few tough years following the pandemic. This, in combination with a lagging share price, improves appeal as I am hoping for a slightly lower valuation before getting involved here. A Bolt-On Deal Haemonetics has reached a deal to acquire Chicago-based Attune Medical in a $160 million cash deal, although that contingency payments mig
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.MarketBeat
- Why You Should Add Haemonetics (HAE) to Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- Apheresis Market Worth $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 [Yahoo! Finance]Yahoo! Finance
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024PR Newswire
HAE
Earnings
- 2/8/24 - Beat
HAE
Sec Filings
- 4/17/24 - Form 4
- 4/1/24 - Form 8-K
- 3/13/24 - Form 4
- HAE's page on the SEC website